PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with …

PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab – read …

Share on Facebook

Tweet

Follow us

Save